NIPH Clinical Trials Search

JAPANESE
国立保健医療科学院
UMIN ID: UMIN000000789

Registered date:10/08/2007

Antiremodeling effect of leukotriene receptor antagonist (pranlukast) in asthmatic subjects with chronic airflow limitation as assessed with computed tomography (CT).

Basic Information

Recruitment status Complete: follow-up continuing
Health condition(s) or Problem(s) studiedasthma
Date of first enrollment2005/06/01
Target sample size30
Countries of recruitmentJapan
Study typeInterventional
Intervention(s)Treatment with pranlukast 450 mg for 24 weeks

Outcome(s)

Primary OutcomeBronchial wall thickness, mean lung density, % low attenuation area
Secondary OutcomePulmonary function tests Sputum eosinophil count Exhaled NO level Procollagen type 1 terminal peptide of sputum supernatant

Key inclusion & exclusion criteria

Age minimum20years-old
Age maximumNot applicable
GenderMale and Female
Include criteria
Exclude criteriaSubjects who suffered from respiratory tract infection in the previous month. Subjects who were taking NSAIDs.

Related Information

Contact

public contact
Name Hirofumi Matsuoka
Address 54 Kawahara, Shyogoin, Sakyo-ku, Kyoto Japan
Telephone 075-751-3830
E-mail
Affiliation Kyoto University Hospital Department of Respiratory Medicine
scientific contact
Name Akio Niimi
Address 54 Kawahara, Shyogoin, Sakyo-ku, Kyoto Japan
Telephone 075-751-3830
E-mail
Affiliation Kyoto University Department of Respiratory Medicine